LISA WEINGARTNER

Leads enterprise commercial strategy and revenue execution for AI-enabled patient engagement and clinical workflow SaaS platform. Responsible for designing and scaling go-to-market motions, driving enterprise pipeline creation, owning forecasting and revenue operations, and leading strategic partnerships across three core verticals: athenaOne, athenaIDX, and McKesson/US Oncology.

• Architected multi-engine enterprise GTM strategy across reseller, co-sell, and platform-partner ecosystems
• Built disciplined revenue forecasting framework and pipeline governance model for executive leadership and board reporting
• Created enterprise deal acceleration playbooks, deal review cadence, and scalable sales processes
• Personally led complex enterprise sales cycles while operating as player-coach to support team development
• Led commercialization of Q2, an agentic AI patient assistant, translating advanced AI capabilities into operational and financial value
• Owns strategic relationships with McKesson, athenaIDX, athenaOne, and national healthcare networks
• Designed structured commercial operating model spanning Sales, Implementation, Customer Success, and Expansion

General Manager reporting to the Chief Commercial Officer in a PE-backed precision medicine technology company. Full P&L ownership of global diagnostics commercial organization across Americas, Europe, and APAC.

• Built and scaled 30+ person global commercial organization across sales, marketing, partnerships and solutions science
• Expanded qualified pipeline >2x to $30M within one year through enterprise GTM strategy redesign
• Established enterprise sales motion for bioinformatics SaaS and clinical genomics platforms
• Closed strategic partnerships with global health systems, diagnostic labs, CROs, and biopharma
• Led executive and board-level forecasting, margin analysis, and revenue reporting
• Drove organizational change to professionalize sales operations and forecasting discipline

Executive leader responsible for national enterprise GTM strategy, strategic partnerships, and revenue growth for genomic care delivery and clinical decision support platform with services.

• Built enterprise revenue channel from zero to multi-million-dollar annual run rate
• Drove 200% year-over-year growth across provider, life sciences, digital health, and payer segments
• Developed strategic partnerships with health systems, IDNs, life sciences organizations, and national reference labs
• Led complex, multi-threaded enterprise sales cycles with C-suite and clinical stakeholders
• Designed scalable forecasting, pipeline management, and revenue operating model
• Regular contributor to executive leadership team and board reporting
• Built and mentored national business development team

Commercial Leader reporting to the CCO focused on business development throughout the U.S. selling the Clinical Genomics Workspace SaaS solution for somatic NGS variant classification, annotation, interpretation and reporting into laboratories performing oncology focused sequencing. Focus was selling into IDNs, biopharma, CROs, large academic medical centers, health systems as well as commercial reference laboratories.

• Managed forecasting and budget for designated territory
• Drafted and negotiated all new customer contracts
• Created national go to market strategy and developed enterprise playbooks for each market vertical
• Managed the sales and implementation processes for all customers
• Successfully closed the majority of new marquis clients for PierianDx post acquisition of Tute

First commercial leadership hire reporting to the COO focused on commercial development domestically and internationally for the Tute cloud-based genomic analysis SaaS solution, which provided genomic variant analysis and interpretation for laboratories sequencing germline gene panels, exomes, and whole genomes.

• Company acquired by PierianDx in 2016

Business Development leader reporting to the CEO heading up the creation and commercialization of the InformedDNA health system clinical decision support offering. Designed and sold the new DNAgateway laboratory utilization management and genetic consultation program to health systems, IDNs and laboratories to ensure reduction in health system genetic testing send out costs and best patient care when genetic testing was ordered.

• Built and designed the DNAgateway utilization management offering from the ground up
• Developed pricing and go to market strategy for laboratory utilization management tool
• Closed Oschner Health System as first new customer within 6 months of hire date
• Developed and implemented nationwide sales strategy and marketing program utilized to close Tier 1 and Tier 2 health systems and IDNs nationwide

Sales Director reporting to VP of Sales for capital equipment / molecular instrumentation startup company. Responsibilities included selling into Hospital Laboratories, Hospital IDNs, and Pathology and Research Laboratories launching new molecular analyzer for infectious disease molecular testing.

• Finished 2012 as the #1 Regional Business Director
• Finished 2013 as the #1 Regional Business Director
• Closed over 15 health systems within 2 years

Sales Director reporting to Chief Commercial Officer for diagnostics startup company. Launched new assay nationwide for identification of rare disease associated with developmental delay.

• Finished 2011 and 2012 as the #1 Regional Business Director
• Launched new diagnostic testing within this market going from 0 ordering docs to 50+ within 4 months
• Led developing Sales Team and participated in all interviews and new hires for the company

District Sales Manager reporting to the Director of Sales Operations. Responsibilities included closing business in challenging/competitive oncology centers and health systems. Managed goal and budget setting for each sales specialist within my district on an annual basis.

• Finished as DSM for #1 Region Nationally 2009
• Finished in the Top 10 DSMs Nationally 2010
• Managed 10 Oncology Sales Specialists throughout Florida
• Worked closely with Director of Sales Operation to launch new Key Account Strategies in market
• Promoted to Florida District Sales Manager, 09/2009

Sales representative selling genetic testing into neurologists, large physician practices, IDNs, health systems and academic medical centers to educate on testing covering 13 different neurological disease states.

• Representative of the Quarter in both Q2 and Q3 2005
• Neurology Sales Representative of the Year 2005
• Successfully completed Athena Prep Mgmnt Program 2006
• Promoted to Regional Trainer 2006

Sales representative selling into health systems and IDNs meeting with pathologists, gastroenterologists, and infectious disease physicians to close contracts with this national reference laboratory. Formulated bids for national contracts and sold individual testing to private practices employed or contracted with territory hospitals.

• Closed New Specialty Lab business in Las Vegas to include Sunrise Hospital worth $500K
• Closed New Specialty Lab business worth $3 million at DSL Labs in Hawaii
• Finished 2003 ranked in Top 10% of Salesforce

One of five Product Specialist positions nationwide who launched new genetic testing for hereditary colon/endometrial cancer.

• Promoted to this position 01/2002
• Increased Colaris business in 2002 for Western Region by over 60% in less than 1 year

Sales representative involved in launch and sales of BRACAnalysis and Colaris genetic testing to physicians in the oncology, gastroenterology, surgical and OBGYN markets.

• Took Territory from 0 Centers of Excellence to 16 within 1 year of hire date
• Increase of overall Territory Sales by an Average of 30% Quarter to Quarter 2000 – 2001
• Promoted to Regional Sales Trainer 2001